Advanced Enzyme Technologies Limited (ADVENZYMES) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs647.13 Million ≈ $7.00 Million USD) by net assets (Rs15.34 Billion ≈ $165.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Advanced Enzyme Technologies Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Advanced Enzyme Technologies Limited - Cash Flow Conversion Efficiency Trend (2008–2026)
This chart illustrates how Advanced Enzyme Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Advanced Enzyme Technologies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hangzhou Electn Soul Network
SHG:603258
|
0.008x |
|
Deutsche Pfandbriefbank AG
XETRA:PBB
|
0.009x |
|
QUADIENT SA ADR1/15/EO 1
F:NEQ0
|
N/A |
|
King’s Town Construction Co Ltd
TW:2524
|
-0.027x |
|
Sandhar Technologies Limited
NSE:SANDHAR
|
0.069x |
|
Qingdao Vland Biotech Co Ltd
SHG:603739
|
0.013x |
|
Sawit Sumbermas Sarana Tbk
JK:SSMS
|
0.038x |
|
Shenzhen Ellassay Fashion Co
SHG:603808
|
0.066x |
Annual Cash Flow Conversion Efficiency for Advanced Enzyme Technologies Limited (2008–2026)
The table below shows the annual cash flow conversion efficiency of Advanced Enzyme Technologies Limited from 2008 to 2026. For the full company profile with market capitalisation and key ratios, see Advanced Enzyme Technologies Limited (ADVENZYMES) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs16.83 Billion ≈ $182.02 Million |
Rs1.73 Billion ≈ $18.66 Million |
0.103x | +0.99% |
| 2025-03-31 | Rs14.69 Billion ≈ $158.83 Million |
Rs1.49 Billion ≈ $16.12 Million |
0.102x | -1.54% |
| 2024-03-31 | Rs13.71 Billion ≈ $148.28 Million |
Rs1.41 Billion ≈ $15.29 Million |
0.103x | -5.67% |
| 2023-03-31 | Rs12.84 Billion ≈ $138.88 Million |
Rs1.40 Billion ≈ $15.18 Million |
0.109x | +1.93% |
| 2022-03-31 | Rs11.40 Billion ≈ $123.33 Million |
Rs1.22 Billion ≈ $13.23 Million |
0.107x | -32.14% |
| 2021-03-31 | Rs10.31 Billion ≈ $111.47 Million |
Rs1.63 Billion ≈ $17.62 Million |
0.158x | -2.71% |
| 2020-03-31 | Rs8.67 Billion ≈ $93.81 Million |
Rs1.41 Billion ≈ $15.24 Million |
0.162x | -10.95% |
| 2019-03-31 | Rs7.05 Billion ≈ $76.22 Million |
Rs1.29 Billion ≈ $13.90 Million |
0.182x | -8.51% |
| 2018-03-31 | Rs5.82 Billion ≈ $62.91 Million |
Rs1.16 Billion ≈ $12.54 Million |
0.199x | -12.24% |
| 2017-03-31 | Rs4.73 Billion ≈ $51.10 Million |
Rs1.07 Billion ≈ $11.61 Million |
0.227x | -34.12% |
| 2016-03-31 | Rs2.83 Billion ≈ $30.65 Million |
Rs977.51 Million ≈ $10.57 Million |
0.345x | +38.92% |
| 2015-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs537.31 Million ≈ $5.81 Million |
0.248x | -23.58% |
| 2014-03-31 | Rs1.71 Billion ≈ $18.50 Million |
Rs555.67 Million ≈ $6.01 Million |
0.325x | +31.07% |
| 2013-03-31 | Rs1.66 Billion ≈ $17.94 Million |
Rs411.24 Million ≈ $4.45 Million |
0.248x | -73.06% |
| 2012-03-31 | Rs984.09 Million ≈ $10.64 Million |
Rs905.46 Million ≈ $9.79 Million |
0.920x | +4950.18% |
| 2011-03-31 | Rs645.35 Million ≈ $6.98 Million |
Rs11.76 Million ≈ $127.15K |
0.018x | -91.07% |
| 2010-03-31 | Rs489.29 Million ≈ $5.29 Million |
Rs99.82 Million ≈ $1.08 Million |
0.204x | -30.61% |
| 2009-03-31 | Rs379.81 Million ≈ $4.11 Million |
Rs111.66 Million ≈ $1.21 Million |
0.294x | +56.82% |
| 2008-03-31 | Rs319.19 Million ≈ $3.45 Million |
Rs59.84 Million ≈ $647.15K |
0.187x | -- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more